CompoAtlas

能量寶石卡尼丁液態膠囊

能量寶石卡尼丁液態膠囊 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
L-CARNITINEL-CARNITINEL-carnitine
WATERWATERNot identified
HYDROXYPROPYL METHYLCELLULOSEHYDROXYPROPYL METHYLCELLULOSENot identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
1120600468
Chinese name
能量寶石卡尼丁液態膠囊
English name
L-CARNITINE 500MG #00141 CAPSULES
Type
Imported tablets and capsules
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
安奕國際企業有限公司
Registration date
2023-03-10
Published validity end
2028-03-10

Original register data

View published fields and their variants
Product name
能量寶石卡尼丁液態膠囊
Active ingredients
L-CARNITINE;;WATER;;HYDROXYPROPYL METHYLCELLULOSE;;WATER;;
Valid until
1170310
Registration number
1120600468
Licence holder
安奕國際企業有限公司
Registration date
1120310
Published reference
DHC0B206004680
Published English name
L-CARNITINE 500MG #00141 CAPSULES

Official source

View the official register, number 1120600468

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • L-CARNITINE
    Read the warning, when it applies and the studies cited

    L-CARNITINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (CPS 2008).

    Sources cited by Health Canada (1)
    • CPS 2008: Compendium of Pharmaceuticals and Specialties: The Canadian Drug Reference for Health Professionals. Ottawa (ON): Canadian Pharmacists Association; 2008.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a seizure disorder (CPS 2008).

    Sources cited by Health Canada (1)
    • CPS 2008: Compendium of Pharmaceuticals and Specialties: The Canadian Drug Reference for Health Professionals. Ottawa (ON): Canadian Pharmacists Association; 2008.

    Health Canada monograph dated 25 July 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “能量寶石卡尼丁液態膠囊”, https://compoatlas.com/en/supplements/taiwan/1120600468-l-carnitine-500mg-00141-capsules, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line